Literature DB >> 28274961

Lipid and lipoprotein abnormalities in acute lymphoblastic leukemia survivors.

Sophia Morel1,2, Jade Leahy1,2, Maryse Fournier1,2, Benoit Lamarche3, Carole Garofalo1, Guy Grimard4, Floriane Poulain1, Edgard Delvin1, Caroline Laverdière1,4, Maja Krajinovic1,4, Simon Drouin1, Daniel Sinnett1,4, Valérie Marcil1,2, Emile Levy5,2,3.   

Abstract

Survivors of acute lymphoblastic leukemia (ALL), the most common cancer in children, are at increased risk of developing late cardiometabolic conditions. However, the mechanisms are not fully understood. This study aimed to characterize the plasma lipid profile, Apo distribution, and lipoprotein composition of 80 childhood ALL survivors compared with 22 healthy controls. Our results show that, despite their young age, 50% of the ALL survivors displayed dyslipidemia, characterized by increased plasma triglyceride (TG) and LDL-cholesterol, as well as decreased HDL-cholesterol. ALL survivors exhibited lower plasma Apo A-I and higher Apo B-100 and C-II levels, along with elevated Apo C-II/C-III and B-100/A-I ratios. VLDL fractions of dyslipidemic ALL survivors contained more TG, free cholesterol, and phospholipid moieties, but less protein. Differences in Apo content were found between ALL survivors and controls for all lipoprotein fractions except HDL3 HDL2, especially, showed reduced Apo A-I and raised Apo A-II, leading to a depressed Apo A-I/A-II ratio. Analysis of VLDL-Apo Cs disclosed a trend for higher Apo C-III1 content in dyslipidemic ALL survivors. In conclusion, this thorough investigation demonstrates a high prevalence of dyslipidemia in ALL survivors, while highlighting significant abnormalities in their plasma lipid profile and lipoprotein composition. Special attention must, therefore, be paid to these subjects given the atherosclerotic potency of lipid and lipoprotein disorders.
Copyright © 2017 by the American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  apolipoproteins; atherosclerosis; cancer; cardiovascular diseases; clinical studies; dyslipidemia; lipid and lipoprotein metabolism; metabolic syndrome

Mesh:

Substances:

Year:  2017        PMID: 28274961      PMCID: PMC5408606          DOI: 10.1194/jlr.M072207

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  76 in total

Review 1.  A review of the role of apolipoprotein C-II in lipoprotein metabolism and cardiovascular disease.

Authors:  Anastazia A Kei; Theodosios D Filippatos; Vasilios Tsimihodimos; Moses S Elisaf
Journal:  Metabolism       Date:  2012-02-02       Impact factor: 8.694

2.  Apolipoprotein CIII and atherosclerosis: beyond effects on lipid metabolism.

Authors:  Alex Bobik
Journal:  Circulation       Date:  2008-08-12       Impact factor: 29.690

3.  Admixed ancestry and stratification of Quebec regional populations.

Authors:  Claude Bherer; Damian Labuda; Marie-Hélène Roy-Gagnon; Louis Houde; Marc Tremblay; Hélène Vézina
Journal:  Am J Phys Anthropol       Date:  2010-11-10       Impact factor: 2.868

4.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

5.  Phenotypic expression of heterozygous lipoprotein lipase deficiency in the extended pedigree of a proband homozygous for a missense mutation.

Authors:  D E Wilson; M Emi; P H Iverius; A Hata; L L Wu; E Hillas; R R Williams; J M Lalouel
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

6.  Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice.

Authors:  Y Ito; N Azrolan; A O'Connell; A Walsh; J L Breslow
Journal:  Science       Date:  1990-08-17       Impact factor: 47.728

7.  The PETALE study: Late adverse effects and biomarkers in childhood acute lymphoblastic leukemia survivors.

Authors:  Sophie Marcoux; Simon Drouin; Caroline Laverdière; Nathalie Alos; Gregor U Andelfinger; Laurence Bertout; Daniel Curnier; Matthias G Friedrich; Ekaterini A Kritikou; Geneviève Lefebvre; Emile Levy; Sarah Lippé; Valérie Marcil; Marie-Josée Raboisson; Frank Rauch; Philippe Robaey; Mariia Samoilenko; Chantal Séguin; Serge Sultan; Maja Krajinovic; Daniel Sinnett
Journal:  Pediatr Blood Cancer       Date:  2016-12-04       Impact factor: 3.167

8.  Low density lipoprotein receptor polymorphisms and the risk of coronary heart disease: the Atherosclerosis Risk in Communities Study.

Authors:  N Franceschini; H Muallem; K M Rose; E Boerwinkle; N Maeda
Journal:  J Thromb Haemost       Date:  2009-03       Impact factor: 5.824

9.  Apolipoprotein C-III isoforms: kinetics and relative implication in lipid metabolism.

Authors:  Jean-François Mauger; Patrick Couture; Nathalie Bergeron; Benoît Lamarche
Journal:  J Lipid Res       Date:  2006-02-22       Impact factor: 5.922

10.  Risk of late effects of treatment in children newly diagnosed with standard-risk acute lymphoblastic leukaemia: a report from the Childhood Cancer Survivor Study cohort.

Authors:  Stefan Essig; Qiaozhi Li; Yan Chen; Johann Hitzler; Wendy Leisenring; Mark Greenberg; Charles Sklar; Melissa M Hudson; Gregory T Armstrong; Kevin R Krull; Joseph P Neglia; Kevin C Oeffinger; Leslie L Robison; Claudia E Kuehni; Yutaka Yasui; Paul C Nathan
Journal:  Lancet Oncol       Date:  2014-06-19       Impact factor: 41.316

View more
  19 in total

Review 1.  Lipid metabolism and carcinogenesis, cancer development.

Authors:  Jia Long; Chan-Juan Zhang; Neng Zhu; Ke Du; Yu-Fang Yin; Xi Tan; Duan-Fang Liao; Li Qin
Journal:  Am J Cancer Res       Date:  2018-05-01       Impact factor: 6.166

2.  Statin use associated with improved overall and cancer specific survival in patients with head and neck cancer.

Authors:  Abhinav Gupta; William Stokes; Megan Eguchi; Mohammad Hararah; Arya Amini; Adam Mueller; Rustain Morgan; Cathy Bradley; David Raben; Jessica McDermott; Sana D Karam
Journal:  Oral Oncol       Date:  2019-02-04       Impact factor: 5.337

Review 3.  Type 2 Diabetes Mellitus, the Metabolic Syndrome, and Its Components in Adult Survivors of Acute Lymphoblastic Leukemia and Hematopoietic Stem Cell Transplantations.

Authors:  Bella Bielorai; Orit Pinhas-Hamiel
Journal:  Curr Diab Rep       Date:  2018-04-18       Impact factor: 4.810

Review 4.  Biomarkers Predictive of Metabolic Syndrome and Cardiovascular Disease in Childhood Cancer Survivors.

Authors:  Alberto Romano; Ester Del Vescovo; Serena Rivetti; Silvia Triarico; Giorgio Attinà; Stefano Mastrangelo; Palma Maurizi; Antonio Ruggiero
Journal:  J Pers Med       Date:  2022-05-27

5.  Metabolic differences among newborns born to mothers with a history of leukemia or lymphoma.

Authors:  Sonia T Anand; Kelli K Ryckman; Rebecca J Baer; Mary E Charlton; Patrick J Breheny; William W Terry; Kord Kober; Scott Oltman; Elizabeth E Rogers; Laura L Jelliffe-Pawlowski; Elizabeth A Chrischilles
Journal:  J Matern Fetal Neonatal Med       Date:  2021-05-12

Review 6.  Metabolic syndrome induced by anticancer treatment in childhood cancer survivors.

Authors:  Hee Won Chueh; Jae Ho Yoo
Journal:  Ann Pediatr Endocrinol Metab       Date:  2017-06-28

7.  CFTR Deletion Confers Mitochondrial Dysfunction and Disrupts Lipid Homeostasis in Intestinal Epithelial Cells.

Authors:  Marie L Kleme; Alain Sané; Carole Garofalo; Ernest Seidman; Emmanuelle Brochiero; Yves Berthiaume; Emile Levy
Journal:  Nutrients       Date:  2018-06-27       Impact factor: 5.717

8.  Prognostic and Therapeutic Value of Apolipoprotein A and a New Risk Scoring System Based on Apolipoprotein A and Adenosine Deaminase in Chronic Lymphocytic Leukemia.

Authors:  Xiaoya Yun; Xiang Sun; Xinting Hu; Huimin Zhang; Zixun Yin; Xin Zhang; Ming Liu; Ya Zhang; Xin Wang
Journal:  Front Oncol       Date:  2021-07-01       Impact factor: 6.244

9.  Multi-Omics Analysis Reveals Disturbance of Nanosecond Pulsed Electric Field in the Serum Metabolic Spectrum and Gut Microbiota.

Authors:  Yeping Dong; Jiahua Lu; Ting Wang; Zhiliang Huang; Xinhua Chen; Zhigang Ren; Liangjie Hong; Haiyu Wang; Dezhi Yang; Haiyang Xie; Wu Zhang
Journal:  Front Microbiol       Date:  2021-07-02       Impact factor: 5.640

10.  The Relationship Between Hematological Malignancy and Lipid Profile.

Authors:  Erman Ozturk
Journal:  Medeni Med J       Date:  2021-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.